Federal award (DELIVERY ORDER, fiscal year 2022)
Recipient: AMERISOURCEBERGEN DRUG CORP
Awarding agency: Department of Defense / Defense Logistics Agency
Funding agency: Department of Defense / Defense Logistics Agency
Period of performance: 2023-03-01 to 2023-03-02
Current total value of award: $2039.51
Description: 4560103252!QUILLIVANT XR ORAL SUSP 60ML 5MG/ML